Cargando…
Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids
Preclinical models that can accurately predict the toxicity and efficacy of candidate drugs to human liver tissue are in urgent need. Human liver organoid (HLO) derived from human pluripotent stem cells offers a possible solution. Herein, we generated HLOs, and demonstrated the utility of these HLOs...
Autores principales: | Wu, Xiaoshan, Jiang, Dacheng, Yang, Yi, Li, Shuang, Ding, Qiurong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981852/ https://www.ncbi.nlm.nih.gov/pubmed/36864321 http://dx.doi.org/10.1186/s13619-022-00148-1 |
Ejemplares similares
-
Predicting In Vivo Anti-Hepatofibrotic Drug Efficacy Based on In Vitro High-Content Analysis
por: Zheng, Baixue, et al.
Publicado: (2011) -
iPSC-Derived Liver Organoids: A Journey from Drug Screening, to Disease Modeling, Arriving to Regenerative Medicine
por: Olgasi, Cristina, et al.
Publicado: (2020) -
“iPSC-derived liver organoids and inherited bleeding disorders: Potential and future perspectives”
por: Roman, Giacomo, et al.
Publicado: (2023) -
Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids
por: Costamagna, Gianluca, et al.
Publicado: (2021) -
hPSC-derived organoids: models of human development and disease
por: Frum, Tristan, et al.
Publicado: (2020)